Unction in the gut of HIVinfected patients. Mucosal Immunol. 2015;8:127?0. 35. Cicala CUnction in the

Unction in the gut of HIVinfected patients. Mucosal Immunol. 2015;8:127?0. 35. Cicala C
Unction in the gut of HIVinfected patients. Mucosal Immunol. 2015;8:127?0. 35. Cicala C, Martinelli E, McNally JP, Goode DJ, Gopaul R, Hiatt J, Jelicic K, Kottilil S, Macleod K, O’Shea A, Patel N, Van Ryk D, Wei D, Pascuccio M, Yi L, McKinnon L, Izulla P, Kimani J, Kaul R, Fauci AS, Arthos J. The integrin 47 forms a complex with cellsurface CD4 and defines a Tcell subset that is highly susceptible to infection by HIV1. Proc Natl Acad Sci USA. 2009;106:20877?2. 36. Yukl SA, Shergill AK, Girling V, Li Q, Killian M, Epling L, Li P, Kaiser P, Haase A, Havlir DV, McQuaid K, Sinclair E, Wong JK. Sitespecific differences in T cell frequencies and phenotypes in the blood and gut of HIVuninfected and ARTtreated HIV + adults. PLoS ONE. 2015;10:e0121290. 37. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints guthoming specificity on T cells. Immunity. 2004;21:527?8. 38. De Milito A. B lymphocyte dysfunctions in HIV infection. Curr HIV Res. 2004;2:11?1. 39. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Mas sive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature. 2005;434:1093?. 40. Ramratnam B, Ribeiro R, He T, Chung C, Simon V, Vanderhoeven J, Hurley A, Zhang L, Perelson AS, Ho DD, Markowitz M. Intensification of antiretroviral therapy accelerates the decay of the HIV1 latent reservoir and decreases, but does not eliminate, ongoing virus replication. J Acquir Immune Defic Syndr. 1999;2004(35):33?. 41. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28242652 K, Margolick J, Brookmeyer R, Gallant J, Markow itz M, Ho DD, NecrosulfonamideMedChemExpress Necrosulfonamide Richman DD, Siliciano RF. Identification of a reservoir for HIV1 in patients on highly active antiretroviral therapy. Science. 1997;278:1295?00. 42. Chun TW, Nickle DC, Justement JS, Meyers JH, Roby G, Hallahan CW, Kottilil S, Moir S, Mican JM, Mullins JI, Ward DJ, Kovacs JA, Mannon PJ, Fauci AS. Persistence of HIV in gutassociated lymphoid tissue despite longterm antiretroviral therapy. J Infect Dis. 2008;197:714?0. 43. Lampinen TM, Critchlow CW, Kuypers JM, Hurt CS, Nelson PJ, Hawes SE, Coombs RW, Holmes KK, Kiviat NB. Association of antiretroviral therapy with detection of HIV1 RNA and DNA in the anorectal mucosa of homo sexual men. AIDS Lond Engl. 2000;14:F69?5. 44. Di Stefano M, Favia A, Monno L, Lopalco P, Caputi O, Scardigno AC, Pas tore G, Fiore JR, Angarano G. Intracellular and cellfree (infectious) HIV1 in rectal mucosa. J Med Virol. 2001;65:637?3. 45. HeyCunningham WJ, Murray JM, Natarajan V, Amin J, Moore CL, Emery S, Cooper DA, Zaunders J, Kelleher AD, Koelsch KK. PINT study team: early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower Tcell activation levels. AIDS Lond Engl. 2015;29:911?. 46. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, PageShafer K, Hsue P, Emu B, Krone M, Lampiris H, Douek D, Martin JN, Deeks SG. Relationship between T cell activation and CD4+ T cell count in HIV seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/27689333 Dis. 2008;197:126?3. 47. Sarmati L, D’Ettorre G, Parisi SG, Andreoni M. HIV replication at low copy number and its correlation with the HIV reservoir: a clinical perspective. Curr HIV Res. 2015;13(3):250?. 48. Saison J, Demaret J, Venet F, Chidiac C, Malcus C, PoitevinLater F, Tardy JC, Ferry T, Monneret G. CD4+ CD25+ CD127- assessment as a surrogate.